MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$12.47
-6.03%
Tradestie Score
33
Market Cap
$2.08B
Revenue Growth
390.7%
Analyst Upside
+196.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.10
-2.81%
|
$1.81B | - | 47 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.19
-2.65%
|
$1.78B | - | 62 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.68
-2.80%
|
$1.78B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$105.85
-5.15%
|
$1.77B | - | 52 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.22
-2.10%
|
$1.74B | - | 37 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.68
-0.52%
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$3.91
-5.33%
|
$1.65B | - | 36 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$43.61
-5.05%
|
$1.63B | 5.5 | 34 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.91
+0.62%
|
$1.57B | - | 42 | Compare |
|
VCEL
Vericel Corporation
|
$57.27
+0.54%
|
$1.56B | 90.3 | 35 | Compare |
More MESO Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry